Heron Therapeutics reported $-56359000 in Net Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
ALKERMES ALKS:US USD -63974000 33.84M
Alnylam Pharmaceuticals ALNY:US USD -405920000 128.52M
Amarin AMRN:US USD -5140000 64.82M
Ani Pharmaceuticals ANIP:US USD -8600000 6.32M
Arrowhead Research ARWR:US USD -72046000 116.41M
Eisai 4523:JP JPY 3.57B 23.33B
Endo International Ordinary Shares ENDP:US USD -722169000 1.16B
Esperion Therapeutics ESPR:US USD -55117000 11.21M
GlaxoSmithKline GSK:LN GBP 10.32B 9.48B
Immunogen IMGN:US USD -77755000 15.73M
Insmed INSM:US USD -131145000 35.5M
JAZZ PHA JAZZ:US USD -19648000 54.31M
Merk MRK:US USD 3.25B 696M
Nektar Therapeutics NKTR:US USD -59049000 100.02M
Neurocrine Biosciences NBIX:US USD 68.5M 85.4M
Omeros OMER:US USD -17456000 13.39M
Pacira Pharmaceuticals PCRX:US USD -693000 20.57M
Regeneron Pharmaceuticals REGN:US USD 1.32B 463.6M
Sangamo Biosciences SGMO:US USD -53155000 9.98M
Teva Pharmaceutical Industries TEVA:US USD 55M 288M
Ultragenyx Pharmaceutical RARE:US USD -245106000 86.94M
Veracyte VCYT:US USD -8723000 809K
Vertex Pharmaceuticals VRTX:US USD 930.5M 120M